FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

Primary tabs

posted by mike kraft on Fri, 2022-08-19 16:38
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound The U.S. Food and Drug Administration (FDA) has ordered Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday. Reuters Reuters

...

Pfizer is "working with the FDA to finalize a protocol to study patients who may be in need of retreatment," and will provide details when available, a company spokesperson said.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -
howdy folks

User login

What is the weather on the sun

Language

English Arabic Danish Dutch Filipino Finnish French German Greek Haitian Creole Hebrew Hindi Indonesian Irish Italian Japanese Korean Persian Portuguese Russian Spanish Swedish Thai Turkish Ukrainian Vietnamese

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Who's online

There are currently 0 users online.

Facebook  Twitter  RSS